Valuation for Catalyst Pharmaceuticals (id:5261 CPRX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 17.94 |
|
|
| Forward P/E | 14.02 |
|
|
| Price to sales | 5.48 |
|
|
| Price to book | 3.82 |
|
|
| Enterprise to revenue | 4.60 |
|
|
| Enterprise to ebitda | 10.03 |
|
|